Prevention of Influenza: Recommendations for Influenza Immunization of Children, 2007–2008
暂无分享,去创建一个
C. Byington | A. Schuchat | R. Frenck | B. Schwartz | L. Rubin | M. Fischer | M. Brady | H. Bernstein | R. Clover | J. Bradley | H. Keyserling | J. Bocchini | C. Baker | L. Pickering | D. Kimberlin | H. Meissner | R. Bortolussi | M. Glodé | P. Dennehy | R. D. Pratt | J. Starke | S. Long | E. O. Ledbetter | Alison Siwek | L. Gorman
[1] R. Keren,et al. Incidence, Complications, and Risk Factors for Prolonged Stay in Children Hospitalized With Community-Acquired Influenza , 2007, Pediatrics.
[2] R. Baltimore,et al. Prevention of Influenza: Recommendations for Influenza Immunization of Children, 2006–2007 , 2007, Pediatrics.
[3] R. Baltimore,et al. Antiviral Therapy and Prophylaxis for Influenza in Children , 2007, Pediatrics.
[4] H. Lawson,et al. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2007, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[5] C. Bridges,et al. Vaccine Effectiveness Against Medically Attended, Laboratory-Confirmed Influenza Among Children Aged 6 to 59 Months, 2003–2004 , 2007, Pediatrics.
[6] R. Walker,et al. Live attenuated versus inactivated influenza vaccine in infants and young children. , 2007, The New England journal of medicine.
[7] T. Stukel,et al. Appropriate measures of influenza immunization program effectiveness , 2006, Vaccine.
[8] Influenza vaccination coverage among children aged 6-23 months--United States, 2005-06 influenza season. , 2007, MMWR. Morbidity and mortality weekly report.
[9] Update: Influenza activity--United States and worldwide, 2006-07 season, and composition of the 2007-08 influenza vaccine. , 2007, MMWR. Morbidity and mortality weekly report.
[10] Influenza vaccination coverage among children aged 6-59 months--six immunization information system sentinel sites, United States, 2006-07 influenza season. , 2007, MMWR. Morbidity and mortality weekly report.
[11] L. Brammer,et al. Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza--Louisiana and Georgia, December 2006-January 2007. , 2007, MMWR. Morbidity and mortality weekly report.
[12] C. Byington,et al. Epidemiology, Complications, and Cost of Hospitalization in Children With Laboratory-Confirmed Influenza Infection , 2006, Pediatrics.
[13] Mandy A. Allison,et al. Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season. , 2006, The Journal of pediatrics.
[14] R. Keren,et al. Direct Medical Cost of Influenza-Related Hospitalizations in Children , 2006, Pediatrics.
[15] C. Bridges,et al. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. , 2006, The Journal of infectious diseases.
[16] T. Lieu,et al. Health Benefits, Risks, and Cost-Effectiveness of Influenza Vaccination of Children , 2006, Emerging infectious diseases.
[17] W. Gruber,et al. Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract Infections , 2006, The Pediatric infectious disease journal.
[18] A. Monto,et al. Immunization With Trivalent Inactivated Influenza Vaccine in Partially Immunized Toddlers , 2006, Pediatrics.
[19] C. Bridges,et al. The underrecognized burden of influenza in young children. , 2006, The New England journal of medicine.
[20] Florence T. Bourgeois,et al. Influenza and Other Respiratory Virus–Related Emergency Department Visits Among Young Children , 2006, Pediatrics.
[21] L. Solberg,et al. Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older. , 2006, American journal of preventive medicine.
[22] D. Thomson,et al. Incidence of influenza in Ontario following the Universal Influenza Immunization Campaign. , 2006, Vaccine.
[23] T. Heikkinen,et al. Cost-effectiveness of influenza vaccination of healthy children. , 2006, Vaccine.
[24] W. Schaffner,et al. Multistate Surveillance for Laboratory-Confirmed, Influenza-Associated Hospitalizations in Children: 2003–2004 , 2006, The Pediatric infectious disease journal.
[25] I. Maral,et al. Effectiveness of Inactivated Influenza Vaccine for Prevention of Otitis Media in Children , 2006, The Pediatric infectious disease journal.
[26] C. Glaser,et al. Severe Pediatric Influenza in California, 2003–2005: Implications for Immunization Recommendations , 2006, Pediatrics.
[27] A. Monto,et al. Influenza Vaccine Immunogenicity in 6- to 23-Month-Old Children: Are Identical Antigens Necessary for Priming? , 2005, Pediatrics.
[28] N. Cox,et al. Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[29] Keiji Fukuda,et al. Influenza-associated deaths among children in the United States, 2003-2004. , 2005, The New England journal of medicine.
[30] R. Yogev. Influenza Vaccine Confusion: A Call for an Alternative Evidence-Based Approach , 2005, Pediatrics.
[31] Ken P Kleinman,et al. Identifying pediatric age groups for influenza vaccination using a real-time regional surveillance system. , 2005, American journal of epidemiology.
[32] Pedro A Piedra,et al. Live Attenuated Influenza Vaccine, Trivalent, Is Safe in Healthy Children 18 Months to 4 Years, 5 to 9 Years, and 10 to 18 Years of Age in a Community-Based, Nonrandomized, Open-Label Trial , 2005, Pediatrics.
[33] M. Kolczak,et al. Effectiveness of the 2003–2004 Influenza Vaccine Among Children 6 Months to 8 Years of Age, With 1 vs 2 Doses , 2005, Pediatrics.
[34] J. Raphaël,et al. [Guillain-Barré syndrome]. , 2005, La Revue du praticien.
[35] Giovanni Apolone,et al. Influenza vaccine in healthy children: a meta-analysis. , 2005, Vaccine.
[36] A. Monto,et al. A Comparison of 2 Influenza Vaccine Schedules in 6- to 23-Month-Old Children , 2005, Pediatrics.
[37] T. Lieu,et al. Values for preventing influenza-related morbidity and vaccine adverse events in children , 2005, Health and quality of life outcomes.
[38] V Demicheli,et al. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review , 2005, The Lancet.
[39] M. Meltzer,et al. An economic analysis of annual influenza vaccination of children. , 2005, Vaccine.
[40] Keiji Fukuda,et al. Influenza-associated hospitalizations in the United States. , 2004, JAMA.
[41] Benjamin Schwartz,et al. Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children. , 2004, Pediatrics.
[42] T. Lieu,et al. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. , 2004, Pediatrics.
[43] D. Krysan. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. , 2004, The Journal of pediatrics.
[44] J. Bartlett,et al. Daptomycin, a new cyclic lipopeptide antibiotic, for the treatment of resistant gram-positive organisms , 2004 .
[45] N. Sugaya. [Influenza virus infection in children]. , 2003, Nihon rinsho. Japanese journal of clinical medicine.
[46] O. Ruuskanen,et al. Influenza A and B virus infections in children. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[47] Keiji Fukuda,et al. Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.
[48] M. Rennels,et al. Reduction of the influenza burden in children. , 2002, Pediatrics.
[49] M. Tashiro,et al. Encephalitis and encephalopathy associated with an influenza epidemic in Japan. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[50] G. Boivin,et al. Prolonged excretion of amantadine-resistant influenza a virus quasi species after cessation of antiviral therapy in an immunocompromised patient. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[51] K. Edwards,et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. , 2002, The Journal of infectious diseases.
[52] M. Peiris,et al. Influenza A infection is an important cause of febrile seizures. , 2001, Pediatrics.
[53] W. Dupont,et al. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience , 2001, The Pediatric infectious disease journal.
[54] Lihan K. Yan,et al. Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children. , 2001, Pediatrics.
[55] K. Nichol,et al. Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. , 2001, Archives of internal medicine.
[56] H. Dibarboure,et al. Safety and immunogenicity of a paediatric presentation of an influenza vaccine , 2000, Archives of disease in childhood.
[57] K. Neuzil,et al. The burden of influenza illness in children with asthma and other chronic medical conditions. , 2000, The Journal of pediatrics.
[58] M. Nettleman,et al. Economic Impact of Influenza Vaccination in Preschool Children , 2000, Pediatrics.
[59] K. O'Brien,et al. Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[60] Lihan K. Yan,et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine. , 2000, The Journal of pediatrics.
[61] E F Mitchel,et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. , 2000, The New England journal of medicine.
[62] R. Davis,et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. , 2000, The New England journal of medicine.
[63] M. Meltzer,et al. The economic impact of pandemic influenza in the United States: priorities for intervention. , 1999, Emerging infectious diseases.
[64] J. A. McCullers,et al. Influenza B virus encephalitis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[65] K. Neuzil,et al. Influenza-associated morbidity and mortality in young and middle-aged women. , 1999, JAMA.
[66] T. Heikkinen,et al. Prevalence of various respiratory viruses in the middle ear during acute otitis media. , 1999, The New England journal of medicine.
[67] L. Simonsen,et al. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. , 1998, American journal of epidemiology.
[68] N. Cox,et al. Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[69] A. Kaplan,et al. Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial. , 1998, Vaccine.
[70] R. Kerstens,et al. IMMUNOGENICITY AND TOLERABILITY OF A TRIVALENT INFLUENZA SUBUNIT VACCINE (INFLUVAC®) IN HIGH‐RISK CHILDREN AGED 6 MONTHS TO 4 YEARS , 1997, The British journal of clinical practice.
[71] J L Nielsen,et al. [Influenza vaccination]. , 1997, Ugeskrift for laeger.
[72] A. Frank,et al. Influenza vaccination of children during acute asthma exacerbation and concurrent prednisone therapy. , 1996, Pediatrics.
[73] E. Walter,et al. Influenza a vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care , 1996 .
[74] N. Cox,et al. Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. , 1995, The Journal of infectious diseases.
[75] N. Sugaya,et al. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B. , 1994, JAMA.
[76] K. Edwards,et al. Serologic response to standard inactivated influenza vaccine in human immunodeficiency virus-infected children. , 1994, The Pediatric infectious disease journal.
[77] M. Levin,et al. Safety and immunogenicity of a purified haemagglutinin antigen in very young high-risk children. , 1994, Vaccine.
[78] J. Patel,et al. Effect of viral respiratory tract infection on outcome of acute otitis media. , 1992, The Journal of pediatrics.
[79] T. Heikkinen,et al. Influenza vaccination in the prevention of acute otitis media in children. , 1991, American journal of diseases of children.
[80] R. Couch,et al. Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. , 1991, The Journal of infectious diseases.
[81] R. Couch,et al. Live attenuated and inactivated influenza vaccine in school-age children. , 1990, American journal of diseases of children.
[82] Henry Nider,et al. Report of the Committee on Infectious Diseases , 1989 .
[83] O. Ruuskanen,et al. Acute otitis media and respiratory virus infections. , 1989, The Pediatric infectious disease journal.
[84] A R Hinman,et al. Assessing vaccine efficacy in the field. Further observations. , 1988, Epidemiologic reviews.
[85] W. P. Glezen,et al. Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981. , 1987, The American review of respiratory disease.
[86] M. Decker,et al. Acute respiratory disease associated with influenza epidemics in Houston, 1981-1983. , 1987, The Journal of infectious diseases.
[87] E. D. Kilbourne,et al. Influenza in Man , 1987 .
[88] B. Murphy,et al. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus , 1986, Journal of clinical microbiology.
[89] W. Barker,et al. Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78. , 1986, American journal of public health.
[90] C. Hall,et al. Influenza A virus infection imitating bacterial sepsis in early infancy , 1984, Pediatric infectious disease.
[91] W. P. Glezen,et al. Trivalent, inactivated influenza virus vaccine in children with sickle cell disease. , 1983, American journal of diseases of children.
[92] A. Monto,et al. Antigenicity and reactogenicity of influenza A/USSR/77 virus vaccine in children--a multicentered evaluation of dosage and safety. , 1983, Reviews of infectious diseases.
[93] J. L. Montagne,et al. Summary of clinical trials of inactivated influenza vaccine - 1978. , 1983, Reviews of infectious diseases.
[94] J. C. Bell,et al. Influenza vaccination. , 1983, JAMA.
[95] R B Couch,et al. Immunity to influenza in man. , 1983, Annual review of microbiology.
[96] J. Mullooly,et al. Impact of type A influenza on children: a retrospective study. , 1982, American journal of public health.
[97] R. Chanock,et al. Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines , 1982, Infection and immunity.
[98] Glezen Wp,et al. SERIOUS MORBIDITY AND MORTALITY ASSOCIATED WITH INFLUENZA EPIDEMICS , 1982 .
[99] W. P. Glezen,et al. Serious morbidity and mortality associated with influenza epidemics. , 1982, Epidemiologic reviews.
[100] P. Steinherz,et al. Immunization against influenza in children with cancer: results of a three-dose trial. , 1982, The Journal of infectious diseases.
[101] J. Mullooly,et al. Impact of epidemic type A influenza in a defined adult population. , 1980, American journal of epidemiology.
[102] J A Bryan,et al. Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977. , 1979, American journal of epidemiology.
[103] J. Oxford,et al. The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection , 1979, Journal of Hygiene.
[104] R. Couch,et al. Interpandemic influenza in the Houston area, 1974-76. , 1978, The New England journal of medicine.
[105] W. Vaughn,et al. Trials of influenza A/New Jersey/76 virus vaccine in normal children: an overview of age-related antigenicity and reactogenicity. , 1977, The Journal of infectious diseases.
[106] D. Tyrrell,et al. The Influenza Viruses and Influenza , 1976 .
[107] A. Monto,et al. The Tecumseh Study of Respiratory Illness. IX. Occurence of influenza in the community, 1966--1971. , 1975, American journal of epidemiology.
[108] A. Monto,et al. The Tecumseh study of respiratory illness. VII. Further observations on the occurrence of respiratory syncytial virus and Mycoplasma pneumoniae infections. , 1971, American journal of epidemiology.